Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies Inc (NASDAQ: ACLS) delivers critical ion implantation systems and semiconductor manufacturing solutions to leading global chipmakers. This page provides investors and industry professionals with a centralized hub for official company announcements, operational updates, and strategic developments.
Access timely updates including earnings reports, product launches, technology partnerships, and service expansions. Our curated collection ensures you stay informed about ACLS's role in advanced logic, silicon carbide processing, and semiconductor equipment innovation.
Discover press releases covering operational milestones, customer collaborations, and advancements in process control technologies. All content is verified for accuracy and relevance to support informed analysis of ACLS's market position and industry contributions.
Bookmark this page for direct access to Axcelis Technologies' latest news. Check regularly for updates on equipment deployments, aftermarket service initiatives, and strategic developments shaping semiconductor manufacturing.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 24th Annual Needham Virtual Growth Conference from January 10-14, 2022. Key executives, including Mary Puma and Kevin Brewer, will host a fireside chat on January 11 at 1:15 p.m. EST, with one-on-one meetings available. A live webcast of the presentation will be accessible via Axcelis' website and will be available for replay for 30 days post-event. This engagement highlights Axcelis' ongoing contributions to the semiconductor industry.
Axcelis Technologies, Inc. (Nasdaq: ACLS) has successfully completed a Purion H™ high current tool evaluation at a top advanced logic device manufacturer. This evaluation is expected to boost high-volume production capabilities for advanced logic devices. Bill Bintz, Executive VP of Product Development, emphasized the positive outlook for 2022 and 2023, citing opportunities for production buys. The Purion H features cutting-edge scanned spot beam technology that enhances device performance and yield while maintaining low operational costs.
Axcelis Technologies (NASDAQ: ACLS) announced its participation in the 10th Annual December CEO Summit on December 8, 2021, in San Francisco, CA. This event coincides with SEMICON West 2021 and involves small group meetings with 11 other companies, including ACM Research and Aehr Test. Attendance is by invitation only for accredited investors and research analysts, with a registration deadline of November 29. Presentation materials will be available on Axcelis' investor page. Proof of COVID vaccination is required for in-person attendees.
Axcelis Technologies (Nasdaq: ACLS) announced a Virtual Investor Day scheduled for December 9, 2021, from 12:00 p.m. ET to 2:00 p.m. ET. The event aims to engage the investment community and will feature presentations from the company's executive team focusing on future growth opportunities, followed by a Q&A session. All executive officers are expected to attend the event. For registration and more details, participants can visit investorday.axcelis.com. An archived version of the webcast will also be available post-event.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the SEMICON Japan 2021 exhibition, set for December 15-17 in Tokyo. The company will showcase its Purion™ and GSD Ovation™ Series of ion implanters at Booth #5731. The Purion Series is noted for its high purity and precision across various applications, while the GSD Ovation Series is designed for 200mm fab construction. CEO Mary Puma highlighted the importance of introducing advanced ion implant technologies to Japanese chipmakers to meet the growing demand in power devices and memory markets.
Axcelis Technologies (NASDAQ: ACLS), a leading supplier in the semiconductor sector, announced its participation in various investor conferences in November and December 2021. Key events include the Benchmark Company Technology Virtual Video 1x1 Investor Conference on November 17, the CEO Summit 2021 in San Francisco on December 8, the 2021 Virtual Investor Day on December 9, and the DA Davidson Semicap, Laser, and Optical Conference on December 15. These conferences provide a platform for management to engage with investors through virtual one-on-ones.
Axcelis Technologies, Inc. (Nasdaq: ACLS) reported strong financial results for Q3 2021, achieving revenue of $176.7 million, up from $147.3 million in Q2. The record system revenue of $126.2 million reflects growth in the implant systems segment. Net income rose to $27.5 million or $0.81 per diluted share, compared to $18.9 million or $0.55 in the previous quarter. The company anticipates approximately $190 million in revenue for Q4, with a gross margin expectation of 41.5%.
Axcelis Technologies (Nasdaq: ACLS) unveiled the GSD Ovation™ high current and high energy batch implanters, aimed at addressing the rising demand in 200mm fab construction. Following a surge since 2015 in 200mm fab activities, the new systems promise seamless integration with existing installations and enhanced 200mm production capabilities. The GSD Ovation family includes models suited for various applications, featuring energies ranging from general high current to high energy applications up to 4.9 MeV. This strategic move reinforces Axcelis' market position as a leader in the semiconductor sector.
Axcelis Technologies, Inc. (Nasdaq: ACLS) announced the shipment of its Purion™ high current and high energy implanters to a major memory device manufacturer in Asia. These shipments, which took place in Q3 and Q4, are intended for high-volume production of DRAM and NAND devices, supporting industries like 5G and AI. Executive VP Bill Bintz emphasized the need for memory manufacturers to enhance productivity while ensuring quality. This order is part of a broader trend towards increasing memory capacity in 2022.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its third quarter 2021 financial results on November 3, 2021, at 4:00 p.m. ET. A conference call to discuss these results is scheduled for November 4, 2021, at 8:30 a.m. ET, available via audio webcast on Axcelis' website. The company has been a provider of innovative solutions for the semiconductor industry for over 40 years, focusing on ion implantation systems and complete lifecycle support.